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Abstract
Background: The aim of the present study was to investigate the age-specific prognostic factors in patients who
underwent gastrectomy for gastric cancer.
Methods: The medical records of 366 patients with gastric cancer who underwent surgical resection at our hospital
between January 2007 and December 2014 were retrospectively reviewed. Of the 366 patients, 117 were aged
75 years or older and 249 were aged 74 years or younger. All factors that were identified as significant using
univariate analysis were included in the multivariate analysis.
Results: The median follow-up duration was 52.9 months (range, 1.0–117.5 months). We found that in patients
aged 75 years or older, postoperative complications and the extent of cancer were independent prognostic factors
of overall survival and disease-free survival. In contrast, in patients aged 74 years or younger, only the lymph node
status and postoperative chemotherapy were independent prognostic factors for overall survival and disease-free
survival, respectively.
Conclusions: Pathological outcomes and postoperative complications are important prognostic factors for survival in
patients aged 75 years or older with gastric cancer, whereas pathological outcomes and postoperative chemotherapy
are important prognostic factors for survival in patients aged 74 years or younger. Because the prevention of
postoperative complications may contribute to improvements in the prognosis of elderly patients with gastric
cancer, we suggest that it is necessary to consider limited surgery instead of radical surgery, depending on the
patient’s general condition and co-morbidities.
Keywords: Gastric cancer, Elderly patient, Prognostic factor, Postoperative complications
Background
Gastric cancer is the fourth most common malignant
disease and the second leading cause of cancer-related
deaths worldwide [1]. In recent years, mortality from
gastric cancer has significantly decreased in Japan be-
cause of advances in diagnostic and treatment modal-
ities, including improvements in screening, surgery, and
chemotherapy [2]. Radical gastrectomy is the mainstay
of curative treatment for gastric cancer. The incidence of
gastric cancer remains relatively high, and particularly in
Japan, the gastric cancer incidence in elderly patients has
been increasing along with the increasing life expectancy
[3]. Characteristics of elderly patients such as declining
physiological function, poor nutritional status, and surgi-
cal trauma from radical gastrectomy appear to result in
higher postoperative morbidity, prolonged hospital stays,
increased healthcare costs, and higher postoperative
mortality. Elderly patients might have poorer prognoses
compared with younger patients primarily because of the
increased risk of postoperative complications. Periopera-
tive nutritional support and preoperative rehabilitation are
beneficial for elderly patients with gastric cancer and can
reduce surgical complications and mortality [4, 5].
As the elderly population increases, it becomes in-
creasingly more important to understand how best to
treat elderly patients with gastric cancer. In the present
retrospective study, we aimed to identify the independ-
ent prognostic factors for survival in elderly patients
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(age ≥75 years) with gastric cancer, with a particular




We investigated a total of 494 consecutive patients with
a histologically confirmed diagnosis of gastric cancer
who were indicated for surgical treatment. They under-
went surgery at the Kawasaki Medical School Hospital
between January 2007 and December 2014, and their re-
cords were reviewed retrospectively. Thirty-four patients
were lost to follow-up, and 94 patients who had metasta-
ses to other organs were excluded. The remaining 366
patients were enrolled in this study. The patients were
divided into two groups according to age: 117 patients
aged 75 years or older (group A) and 249 patients aged
74 years or younger (group B) (Fig. 1). Comorbidities
were estimated using the Charlson Comorbidity Index
(CCI) [6] with the exclusion of gastric cancer as a co-
morbidity. The pathological characteristics of the tumors
were assessed according to the 3rd English edition of the
Japanese Classification of Gastric Carcinoma [7]. The ac-
tivities of daily living were evaluated using the American
Society of Anesthesiologists-Physical Status (ASA-PS)
scale [8]. We have summarized the patient characteris-
tics in Table 1. The Institutional Review Board of Kawa-
saki Medical School approved this study (No. 1935).
Pathological diagnosis
Histopathologically, papillary and tubular adenocarcin-
omas were classified as intestinal type adenocarcinomas,
and poorly differentiated signet ring cell and mucinous
adenocarcinomas were classified as diffuse type adeno-
carcinomas. The degrees of lymphatic (ly0, 1, and 2) and
venous (v0, 1, and 2) invasion were defined according to
the Japanese Classification of Gastric Carcinoma [7].
Tumors were classified according to size as ≥5 or <5 cm.
Inflammatory responses and nutrition
The systemic inflammatory responses were classified
into three groups according to the modified Glasgow
Fig. 1 Enrollment and follow-up of the patients














Pathological stage I/II/III 236/70/60
Postoperative complications
C. D. grade I/II/III/IV/V 11/17/16/2/3
Curability A/B/C 362/4/0




ASA-PS American Society of Anesthesiologists-Physical Status, CCI Charlson
comorbidity score, DG distal gastrectomy, TG total gastrectomy, LADG
laparoscopic-assisted distal gastrectomy, LR local resection, C.D. Clavien–
Dindo, PNI prognostic nutritional index
aWithout gastric cancer
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Prognostic Score (mGPS 0, 1, and 2). The GPS was
modified as follows: 0 = serum C-reactive protein (CRP)
concentration ≤10 mg/L, 1 = CRP >10 mg/L and serum
albumin concentration ≥35 g/L, and 2 = CRP >10 mg/L
and albumin <35 g/L [9]. The Onodera prognostic
nutritional index (PNI) was determined according to
the following formula: 10 × serum albumin concentra-
tion (g/dL) + 0.005 × total lymphocyte count (/mm3)
[10]. The Onodera PNI was implemented in the follow-
ing scoring system: good nutrition, >50; mild malnutri-
tion, 45–50; moderate malnutrition, 40–45; and severe
malnutrition, <40.
Surgery
The details of the surgical procedures are given in Table 1.
Patients who underwent total or distal gastrectomy also
underwent D1+ or D2 lymph node dissection in accord-
ance with the Japanese gastric cancer treatment guidelines
2010 (ver. 3) [7]. In distal gastrectomy, the resected nodes
included No. 1, 3, 4sd, 4d, 5, 6, 7, 8a, and 9 for D1+ lymph
node dissection, and additional nodes No. 11p and 12a for
D2 lymph node dissection. In total gastrectomy, the
resected nodes included No. 1, 2, 3, 4sa, 4sb, 4d, 5, 6, 7,
8a, 9, and 11p for D1+ lymph node dissection, and add-
itional nodes No. 10, 11d, and 12a for D2 lymph node
dissection. In principle, D1+ lymphadenectomy was per-
formed in patients with cT1N0 tumors for whom endo-
scopic mucosal resection or endoscopic submucosal
dissection was indicated and in those who demonstrated
signs of metastatic invasion. D2 lymphadenectomy was
performed in patients with potentially curable stage T2–
4 tumors and in those with cT1NX tumors.
Briefly, as a part of partial cardiectomy, lymph node
dissection along the lesser curvature and left pericardial
portion of the stomach was performed, followed by the
incision of two or three branches of the upper short gas-
tric vessels to create the new fornix and the anastomosis
of the primary fornix to the distal edge of the subse-
quent gastrectomy [11]. Local resection was performed
with a 2-cm cancer-free margin. The area for lymphade-
nectomy was determined by the lymphatic flow from the
tumor [12, 13].
Postoperative complications
Postoperative complications were assessed according to
the Clavien–Dindo classification [14]. Surgical site infec-
tions (SSIs) were defined in accordance with the criteria
of the Center for Disease Control and Prevention [15].
The incisional SSI diagnosis criteria included infections
that occurred within 30 days after surgery.
Follow-up
The follow-up schedule of patients with pT1 tumors
after gastrectomy included physical examinations, serum
analyses (including analyses of carcinoembryonic antigen,
carbohydrate antigen 19-9, and carbohydrate antigen 125),
abdominal ultrasonography or computed tomography per-
formed at least once every 6 months, and an annual gas-
troscopy for a period of 5 years. In patients with pT2–4
tumors, the follow-up schedule after gastrectomy included
the examinations described for pT1 tumors; however,
they were performed at least once every 3 months for a
period of 3 years, and an annual gastroscopy for a period
of 5 years.
Chemotherapy
Tegafur-gimestat-otastat potassium (TS-1) was adminis-
tered as first-line adjuvant chemotherapy in patients
who underwent curative gastrectomy for stage II and III
tumors in accordance with the findings and guidelines of
the Adjuvant Chemotherapy Trial of TS-1 for Gastric
Cancer study [16]. TS-1 plus paclitaxel or cisplatin, or
TS-1 monotherapy in cases of high-risk patients, was ad-
ministered to patients with stage IV disease who had
undergone gastrectomy.
Statistical analyses
Overall survival (OS) was defined as the interval between
surgery and the date of death due to any cause. Disease-
specific survival (DSS) was defined as the interval between
surgery and the date of death from gastric cancer. Patients
who were lost to follow-up were excluded. The OS and
DSS were calculated using the Kaplan–Meier method
and compared using the log-rank test. Univariate and
multivariate analyses were performed using the Cox
proportional hazards model. P values <0.05 were de-
fined as statistically significant. All statistical analyses
were performed using JMP 10 software (SAS Institute,
Cary, NC, USA).
Results
The median follow-up duration was 52.9 months (range,
1.0–117.5 months). One patient died within 30 days
after surgery. At the end of the follow-up period, 74
patients had died, 41 from unrelated causes including
respiratory disease (34.1%), other cancers (19.5%), senile
dementia (17.1%), circulatory disease (12.2%), cerebro-
vascular disease (7.3%), suicide (2.4%), and unclear cause
but not cancer (7.3%), respectively.
In group A, combined resection included 1 case of
colon resection, 25 cases of gallbladder resection, 1 case of
distal pancreatectomy, 4 cases of spleen resection, and 1
case of kidney resection. In group B, combined resection
included 7 cases of colon resection, 16 cases of gallbladder
resection, 7 cases of distal pancreatectomy, 30 cases of
spleen resection, and 1 case of kidney resection. Postoper-
ative complications are summarized in Table 2. The total
number of postoperative complications was 20 in group A
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and 29 in group B. There were no significant differences
between type of surgeries. The CCI of group A was sig-
nificantly higher than that of group B (3.37 vs. 2.52; p <
0.001). Similar results were obtained for all other condi-
tions except for gastric cancer (1.84 vs. 0.67; p < 0.001).
In addition, patients with tumors other than gastric can-
cer were significantly more common in group A than in
group B (28 vs. 19; p < 0.001). The 5-year OS rates for
stage I, II, III, and IV gastric cancers were 90.7, 72.8,
44.6, and 13.4%, respectively, and the 5-year DSS rates
were 99.5, 83.6, 56.6, and 14.5%, respectively.
A univariate Cox regression analysis was performed
with the following variables: sex, ASA-PS score, type of
surgery, histology, tumor size, depth of invasion (T),
lymphatic invasion (ly), venous invasion (v), lymphatic
metastasis (N), postoperative complications classified
according to the Clavien–Dindo method [14], Onodera
PNI [10], mGPS score [9], and postoperative chemo-
therapy (Tables 3 and 4). In group A, the ASA-PS
score, surgery, tumor size, T, ly, v, N, postoperative
complications, and Onodera PNI were identified as sig-
nificant prognostic factors for both OS and DSS. Subse-
quently, these factors were included in a multivariate
Cox regression analysis, which identified postoperative
complications as independent prognostic factors for
OS. The ASA-PS score, T, v, N, and postoperative com-
plications were also independent prognostic factors for
DSS (Table 3).
The same factors were included in a univariate Cox
regression analysis for group B, which identified the
ASA-PS score, surgery, tumor size, T, ly, v, N, Onodera
PNI, mGPS score, and chemotherapy as independent
prognostic factors for OS. In addition, surgery, tumor
size, T, ly, v, N, Onodera PNI, mGPS score, and chemo-
therapy were identified as independent prognostic fac-
tors for DSS. Subsequently, these factors were included
in a multivariate Cox regression analysis, which identi-
fied N as an independent prognostic factor for OS. T,
ly, N, and chemotherapy were identified as independent
prognostic factors for DSS (Table 4). These findings of
the univariate and multivariate analyses are summa-
rized in Tables 5 and 6.
Discussion
Surgical resection is the main curative treatment op-
tion for patients with gastric cancer. However, disease
recurrence occurs in 20–60% of these patients despite
curative resection [17–19]. The high mortality and re-
lapse rates in patients with gastric cancer are attribut-
able to the extent of surgery and aggressiveness of the
cancer [20, 21].
The potential benefits of surgery for elderly patients
with gastric cancer must be explored in the context of
their shorter life expectancy compared to younger
patients. Moreover, elderly patients are more likely to
exhibit functional declines in some organs, making it
more difficult to overcome surgical stress. We hypothe-
sized that postoperative complications and preoperative
nutritional status might be risk factors after gastrec-
tomy for gastric cancer, particularly in patients aged
75 years or older.
The development of postoperative complications is an
important prognostic indicator in patients with cancer,
and technical complications such as anastomotic leak-
age, vocal cord paralysis, and chylothorax have a major
negative effect on survival after esophagogastrectomy
[22]. Indeed, anastomotic leakage has been shown to be
a major independent prognostic factor in all patients
after undergoing gastrectomy for cancer [23] and a
major independent prognostic factor for long-term sur-
vival in patients with advanced gastric cancer [24, 25].
The development of postoperative complications has
also been reported to be an independent prognostic fac-
tor for long-term survival after surgery for esophageal
cancer [24, 26, 27].
Several studies have reported the importance of
nutritional support during the perioperative period.
Enteral nutrition via a nasoenteral feeding tube during
the early postoperative period is associated with signifi-
cantly fewer postoperative complications in patients
who undergo radical surgery for gastric cancer [28]. In
addition, it was reported that patients with severe mal-
nutrition and gastrointestinal dysfunction might benefit
from preoperative parenteral nutrition [29]. Enteral
plus parenteral nutrition is the optimal means of ad-
ministering postoperative nutritional support in elderly
patients with gastric cancer [30].





Incisional SSI 5 (4.3%) 4 (1.6%)
Pancreatic fistula 3 (2.6%) 6 (2.4%)
Anastomotic leakage 3 (2.6%) 10 (4.0%)
Pneumonia 2 (1.7%) 2 (0.8%)
AKI 2 (1.7%) 0 (0%)
Anastomotic ulcer 1 (0.8%) 1 (0.4%)
Anastomotic edema 1 (0.8%) 0 (0%)
Pulmonary embolism 1 (0.8%) 0 (0%)
Sigmoid colon volvulus 1 (0.8%) 0 (0%)
Sudden death 1 (0.8%) 0 (0%)
CRBSI 0 (0%) 2 (0.8%)
Postoperative bleeding 0 (0%) 2 (0.8%)
Chylous ascites 0 (0%) 2 (0.8%)
SSI surgical site infection, AKI acute kidney injury, CRBSI catheter-related blood
stream infection
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The incorporation of the Onodera PNI into a nutri-
tional scoring system is a simple and useful method for
identifying patients at an increased risk of postoperative
complications and for predicting long-term survival after
total gastrectomy [31]. This index serves as a valuable
preoperative clinical marker and a prognostic indicator
in elderly patients with colorectal cancer [32].
Hirai et al. [31] reported that surgical stress and post-
operative complications had adverse effects on the prog-
noses of patients undergoing cancer surgery. This
phenomenon is referred to as “surgical oncotaxis”, and it
has become increasingly recognized as an important factor
in multidisciplinary cancer treatments. Minimal invasive-
ness is therefore an important principle of cancer surgery.
In the present study, we demonstrated that the stage
of cancer progression, Onodera PNI, and postoperative
complications were prognostic indicators for OS and
DSS in patients with gastric cancer aged 75 years or
older. Moreover, a multivariate analysis identified post-
operative complications as independent prognostic fac-
tors of survival and the Onodera PNI was associated
with the incidence of postoperative complications in
older patients. In contrast, postoperative chemotherapy
was the only independent prognostic factor for DSS
other than the extent of the tumor in patients aged
74 years or younger. Our results suggest that postopera-
tive complications might be more deleterious in elderly
patients than in younger patients. Elderly patients might
experience more severe complications owing to the
characteristics of surgery, such as severe invasiveness.
Therefore, nutrition and rehabilitation must be provided
to elderly patients after surgery, less invasive surgical
methods should be selected, and postoperative complica-
tions should be prevented as much as possible.
As described above, the CCI of group A was signifi-
cantly higher than in group B. Moreover, patients whose
CCI score was 5 were significantly more likely to be in
group A (18 vs. 11; p < 0.001). Frenkel et al. showed that
patients whose CCI score was 5 or more had higher
rates of 3-month (odds ratio (OR) = 3.6), 1-year (OR =
7.1), and 5-year (OR = 52.4) mortality than those with a
CCI score of 0 [33].
Table 6 Significant prognostic factors for overall survival and disease-specific survival in patients younger than 74 years
Overall survival Disease-specific survival
Univariate analysis Multivariate analysis Univariate analysis Multivariate analysis
ASA-PS N Surgery T
Surgery Tumor size ly





Onodera PNI Modified GPS
Modified GPS Postoperative chemotherapy
Postoperative chemotherapy
ASA-PS American Society of Anesthesiologists-Physical Status, GPS Glasgow prognostic score, PNI prognostic nutritional index
Table 5 Significant prognostic factors for overall survival and disease-specific survival in patients older than 75 years
Overall survival Disease-specific survival
Univariate analysis Multivariate analysis Univariate analysis Multivariate analysis
ASA-PS Postoperative complications ASA-PS ASA-PS
Surgery Surgery T
Tumor size Tumor size v
T T N
ly ly Postoperative complications
v v
N N
Postoperative complications Postoperative complications
Onodera PNI Onodera PNI
ASA-PS American Society of Anesthesiologists-Physical Status, PNI prognostic nutritional index
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Many postoperative complications result in infec-
tions. The precise mechanism of postoperative com-
plications influencing the prognosis remains to be
determined. However, there are two possible mecha-
nisms [34]: (1) The enhancement of innate biological
factors during infection or those produced by the
infection-causing bacteria may directly activate cancer
cells to proliferate and acquire metastatic potential.
Cytokines such as tumor necrosis factor-α, interleukin-
1, IL-6, and IL-18; oxygen free radicals; and nitrogen-
based biological effectors have all been implicated in
promoting cancer cell growth. (2) A deregulated host
immune response during infection may also contribute
to tumorigenesis. Therefore, postoperative complica-
tions could lead to tumor growth, which leads to
poorer outcomes. Rausei et al. suggested that D1
lymphadenectomy should be considered in elderly pa-
tients and/or patients with highly co-morbid gastric
cancer due to their high postoperative complication
rates and no significant improvement of their overall
survival [35].
In patients with high-risk gastric cancer (e.g., severe
aortic valve stenosis, chronic obstructive pulmonary
disease, and age >90 years), local resection is used for
treating cases with up to submucosal invasion in our
department. In addition, all cases of local resection
were intended to be curative. Moreover, postoperative
complications from local resection were rare in our
study (1/15). Only one case had a confirmed recur-
rence, and all patients survived (mean follow-up
48.0 months).
Elderly patients in our cohort had significantly more
comorbidities than younger patients did; these comor-
bidities might increase the risks of surgery and affect
their prognosis. Based on this hypothesis, we usually
perform limited surgery for elderly patients instead of
curative aggressive surgery. We believed that the present
study might prove this hypothesis to be correct. The re-
sults of the present study suggest that it is necessary to
consider less invasive surgery to reduce postoperative
complications as well as radical surgery for the elderly
depending on each patient’s general condition.
However, the present study had some limitations in-
cluding a relatively small sample size, short follow-up
duration, and selection bias. We cannot be sure there
was no selection bias. However, if radical surgery was
possible, surgery was performed regardless of age.
Therefore, we think that the risk of selection bias is not
large. In addition, the preliminary findings of the present
study should be validated in a larger patient cohort with
a longer follow-up duration. Nonetheless, our findings
have demonstrated the importance of nutritional status
and perioperative nutritional support in elderly patients
with gastric cancer who undergo gastrectomy.
Conclusions
Our findings suggest that pathological outcomes and
postoperative complications are predictors of survival in
patients with gastric cancer aged 75 years or older,
whereas pathological outcomes and chemotherapy are
predictors of survival in patients aged 74 years or youn-
ger. Because the prevention of postoperative complica-
tions may contribute to improved prognosis for elderly
patients with gastric cancer, we suggest that it is neces-
sary to consider limited surgery instead of radical sur-
gery depending on each patient’s general condition and
comorbidities. Further evaluation of potential prognostic
factors is imperative for the improvement of long-term
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